Literature DB >> 30056268

Characterization of Human Serum Albumin isoforms by ion exchange chromatography coupled on-line to native mass spectrometry.

Y Leblanc1, N Bihoreau1, G Chevreux2.   

Abstract

Human Serum Albumin is the most abundant protein of the plasma and displays a wide range of non-oncotic properties such as antioxidant activity, distribution in tissues and organs of binding molecules and clearance of toxic compounds. Albumin is susceptible to numerous post-translational modifications and particularly related to its free thiol group at Cys34 which is the main circulating scavenger of reactive oxygen species. The characterization of these modifications is of high interest for the diagnosis and treatment of patients with liver diseases and for the structural integrity assessment of albumin as a therapeutic protein. In this study, an ion exchange chromatographic method coupled on-line to native mass spectrometry was developed in order to bridge an effective charge variants separation method with a powerful identification technique for a detailed characterization of albumin isoforms. The chromatographic performance of the method allows the separation of 9 different isoforms that were on-line characterized by MS as oxidized, glycated, deamidated and N/C-terminal truncated forms. The method is also able to detect Cu(II) ions binding to the N-terminal site of the protein which is an important antioxidant feature of albumin. Finally, the method showed preliminary good performance parameters in term of linearity, precision and sensitivity for characterization of purified albumin as well as albumin from raw plasma for clinical and pharmaceutical purposes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Charge variants; Human Serum Albumin; Ion exchange chromatography; Mass spectrometry; Oxidation

Mesh:

Substances:

Year:  2018        PMID: 30056268     DOI: 10.1016/j.jchromb.2018.07.014

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  A low-cost self-dispersing method of droplet array generation enabled by a simple reusable mask for bioanalysis and bioassays.

Authors:  Kai Liu; Yang Pan; Xiaojie Wang; Tuo Ma; Baoqing Li; Jiaru Chu
Journal:  Anal Bioanal Chem       Date:  2021-11-15       Impact factor: 4.142

2.  Transthyretin proteoforms of intraocular origin in human subretinal fluid.

Authors:  Jianzhong Chen; Dongfeng Cao; Seth D Fortmann; Christine A Curcio; Richard M Feist; Jason N Crosson
Journal:  Exp Eye Res       Date:  2022-06-26       Impact factor: 3.770

3.  Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions.

Authors:  Yann Leblanc; Marie Berger; Alexander Seifert; Nicolas Bihoreau; Guillaume Chevreux
Journal:  Protein Sci       Date:  2019-11       Impact factor: 6.725

4.  Native Liquid Chromatography and Mass Spectrometry to Structurally and Functionally Characterize Endo-Xylanase Proteoforms.

Authors:  Guusje van Schaick; Nadi El Hajjouti; Simone Nicolardi; Joost den Hartog; Romana Jansen; Rob van der Hoeven; Wim Bijleveld; Nicolas Abello; Manfred Wuhrer; Maurien M A Olsthoorn; Elena Domínguez-Vega
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

5.  Coupling Anion Exchange Chromatography with Native Mass Spectrometry for Charge Heterogeneity Characterization of Monoclonal Antibodies.

Authors:  Anita P Liu; Yuetian Yan; Shunhai Wang; Ning Li
Journal:  Anal Chem       Date:  2022-04-14       Impact factor: 8.008

6.  Charting the Proteoform Landscape of Serum Proteins in Individual Donors by High-Resolution Native Mass Spectrometry.

Authors:  Dario A T Cramer; Vojtech Franc; Tomislav Caval; Albert J R Heck
Journal:  Anal Chem       Date:  2022-09-08       Impact factor: 8.008

Review 7.  Serum Albumin Redox States: More Than Oxidative Stress Biomarker.

Authors:  Fuka Tabata; Yasuaki Wada; Satomi Kawakami; Kazuhiro Miyaji
Journal:  Antioxidants (Basel)       Date:  2021-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.